COMMON STOCK PURCHASE WARRANT Elite Pharmaceuticals, inc.Common Stock Purchase Warrant • April 28th, 2017 • Elite Pharmaceuticals Inc /Nv/ • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Mr. Nasrat Hakim or his assigns (the “Holder”) is entitled, upon the terms and subject to the limitations (including, but not limited to, the Company obtaining shareholder approval to increase the number of the Company’s authorized shares of Common Stock to permit exercise of the Warrant as required by Section 2(g) below) and the conditions hereinafter set forth, at any time on or after the Initial Exercise Date and on or prior to the close of business on the tenth (10) year anniversary of the Issue Date, or earlier as set forth in Section 5 below (the “Termination Date”) but not thereafter (the “Exercise Period”), to subscribe for and purchase from Elite Pharmaceuticals, Inc., a Nevada corporation (the “Company”), up to 79,008,661 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the
EXCHANGE AGREEMENTExchange Agreement • April 28th, 2017 • Elite Pharmaceuticals Inc /Nv/ • Pharmaceutical preparations • New Jersey
THIS EXCHANGE AGREEMENT (the “Agreement”), dated as of April 28, 2017, is made by and between ELITE PHARMACEUTICALS, INC., a Nevada corporation (the “Company”), and Nasrat Hakim (the “Holder” and, along with the Company, the “Parties”), as a holder of the Hakim Shares (as defined below).
